Gene · 1737
Papers2,650
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,650
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring Determinants of Sustained Participation in New Sports: The Impact of YouTube Engagement and Educator Support. | Behav Sci (Basel) | 2024 | 39457786 | PubTator, text mining | PubMed |
| Comprehensive analysis of the expression level, prognostic value, and immune infiltration of cuproptosis-related genes in human breast cancer. | Medicine (Baltimore) | 2024 | 39432636 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis-related genes involved in prognosis and tumor microenvironment infiltration of colorectal cancer. | Transl Cancer Res | 2024 | 39430854 | PubTator, text mining | PubMed |
| Hollow Calcium/Copper Bimetallic Amplifier for Cuproptosis/Paraptosis/Apoptosis Cancer Therapy via Cascade Reinforcement of Endoplasmic Reticulum Stress and Mitochondrial Dysfunction. | ACS Nano | 2024 | 39412236 | PubTator, text mining | PubMed |
| Dihydrolipoamide S-acetyltransferase activation alleviates diabetic kidney disease via AMPK-autophagy axis and mitochondrial protection. | Transl Res | 2024 | 39389296 | PubTator, text mining | PubMed |
| ATP-responsive copper(II)-doped ZIF-nanoparticles for synergistic cancer therapy: combining cuproptosis and chemo/chemodynamic therapy. | J Mater Chem B | 2024 | 39380332 | PubTator, text mining | PubMed |
| Bioinformatics study of DLAT gene in pan-cancer. | Asian J Surg | 2024 | 39368953 | PubTator, text mining | PubMed |
| Identification of potential biomarkers of cuproptosis in cerebral ischemia. | Front Nutr | 2024 | 39360273 | PubTator, text mining | PubMed |
| Bovine serum albumin-bound homologous targeted nanoparticles for breast cancer combinatorial therapy. | Int J Biol Macromol | 2024 | 39343270 | PubTator, text mining | PubMed |
| Redox-manipulating nanocarriers for anticancer drug delivery: a systematic review. | J Nanobiotechnology | 2024 | 39342211 | PubTator, text mining | PubMed |
| Theory and Measurement of Heat Transport in Solids: How Rigidity and Spectral Properties Govern Behavior. | Materials (Basel) | 2024 | 39336210 | PubTator, text mining | PubMed |
| Tumor Microenvironment Activated Cu Crosslinked Near-Infrared Sonosensitizers for Visualized Cuproptosis-Enhanced Sonodynamic Cancer Immunotherapy. | Adv Sci (Weinh) | 2024 | 39331855 | PubTator, text mining | PubMed |
| How to maximize the travelers' shift to rail transit in a Chinese valley city after bus fare adjustment. | Heliyon | 2024 | 39281603 | PubTator, text mining | PubMed |
| Injectable Hydrogel-Encapsulating Pickering Emulsion for Overcoming Lenvatinib-Resistant Hepatocellular Carcinoma via Cuproptosis Induction and Stemness Inhibition. | Polymers (Basel) | 2024 | 39274051 | PubTator, text mining | PubMed |
| Evaluation of a Ten-Antigen Immunodot Test in Autoimmune Hepatitis and Primary Biliary Cholangitis: Lessons Learned for a Tertiary Care Academic Hospital. | Diagnostics (Basel) | 2024 | 39272667 | PubTator, text mining | PubMed |
| Apoptosis and cuproptosis Co-activated Copper-based metal-organic frameworks for cancer therapy. | J Nanobiotechnology | 2024 | 39237931 | PubTator, text mining | PubMed |
| Cu Nanowires Trigger Efficient Cuproptosis via Special Intracellular Distribution and Excessive Cu Ion Release. | Nano Lett | 2024 | 39225511 | PubTator, text mining | PubMed |
| Triptolide-induced cuproptosis is a novel antitumor strategy for the treatment of cervical cancer. | Cell Mol Biol Lett | 2024 | 39198750 | PubTator, text mining | PubMed |
| Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives. | J Hematol Oncol | 2024 | 39152464 | PubTator, text mining | PubMed |
| Mitochondrial copper overload promotes renal fibrosis via inhibiting pyruvate dehydrogenase activity. | Cell Mol Life Sci | 2024 | 39120696 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1737/papers?page=18